283 related articles for article (PubMed ID: 18284399)
1. Demographic and clinical correlates of extent of psoriasis during stable disease and during flares in chronic plaque psoriasis.
Osborne JE; Hutchinson PE
Br J Dermatol; 2008 Apr; 158(4):721-6. PubMed ID: 18284399
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study.
Rigopoulos D; Gregoriou S; Stratigos A; Larios G; Korfitis C; Papaioannou D; Antoniou C; Ioannides D
Br J Dermatol; 2008 Aug; 159(2):453-6. PubMed ID: 18565184
[TBL] [Abstract][Full Text] [Related]
3. Is facial involvement a sign of severe psoriasis?
Canpolat F; Cemil BC; Eskioğlu F; Akis HK
Eur J Dermatol; 2008; 18(2):169-71. PubMed ID: 18424377
[TBL] [Abstract][Full Text] [Related]
4. Classification of facial psoriasis based on the distributions of facial lesions.
Woo SM; Choi JW; Yoon HS; Jo SJ; Youn JI
J Am Acad Dermatol; 2008 Jun; 58(6):959-63. PubMed ID: 18359126
[TBL] [Abstract][Full Text] [Related]
5. Extended report: nail disease in psoriatic arthritis--clinically important, potentially treatable and often overlooked.
Williamson L; Dalbeth N; Dockerty JL; Gee BC; Weatherall R; Wordsworth BP
Rheumatology (Oxford); 2004 Jun; 43(6):790-4. PubMed ID: 15113998
[TBL] [Abstract][Full Text] [Related]
6. Analysis of phenotypic variation in psoriasis as a function of age at onset and family history.
Stuart P; Malick F; Nair RP; Henseler T; Lim HW; Jenisch S; Voorhees J; Christophers E; Elder JT
Arch Dermatol Res; 2002 Jul; 294(5):207-13. PubMed ID: 12115023
[TBL] [Abstract][Full Text] [Related]
7. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794
[TBL] [Abstract][Full Text] [Related]
8. The burden of nail psoriasis: an introduction.
Baran R
Dermatology; 2010; 221 Suppl 1():1-5. PubMed ID: 20733309
[TBL] [Abstract][Full Text] [Related]
9. Approach to managing patients with nail psoriasis.
Reich K
J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():15-21. PubMed ID: 19686381
[TBL] [Abstract][Full Text] [Related]
10. Plaque thickness and morphology in psoriasis vulgaris associated with therapeutic response.
Rakkhit T; Panko JM; Christensen TE; Wong B; Nelson T; Papenfuss J; Hansen CB; Callis-Duffin K; Krueger GG
Br J Dermatol; 2009 May; 160(5):1083-9. PubMed ID: 19222464
[TBL] [Abstract][Full Text] [Related]
11. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical features of HLA-Cw*0602-positive and -negative psoriasis patients in a Han Chinese population.
Fan X; Yang S; Sun LD; Liang YH; Gao M; Zhang KY; Huang W; Zhang X
Acta Derm Venereol; 2007; 87(4):335-40. PubMed ID: 17598037
[TBL] [Abstract][Full Text] [Related]
13. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India.
Kaur I; Dogra S; De D; Kanwar AJ
Pediatr Dermatol; 2008; 25(2):184-8. PubMed ID: 18429775
[TBL] [Abstract][Full Text] [Related]
14. Interobserver reliability of the Nail Psoriasis Severity Index.
Aktan S; Ilknur T; Akin C; Ozkan S
Clin Exp Dermatol; 2007 Mar; 32(2):141-4. PubMed ID: 17137477
[TBL] [Abstract][Full Text] [Related]
15. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis.
Cassell SE; Bieber JD; Rich P; Tutuncu ZN; Lee SJ; Kalunian KC; Wu CW; Kavanaugh A
J Rheumatol; 2007 Jan; 34(1):123-9. PubMed ID: 17216680
[TBL] [Abstract][Full Text] [Related]
16. In vivo quantification of the structural abnormalities in psoriatic microvessels before and after pulsed dye laser treatment.
Hern S; Stanton AW; Mellor RH; Harland CC; Levick JR; Mortimer PS
Br J Dermatol; 2005 Mar; 152(3):505-11. PubMed ID: 15787819
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of psoriasis in Greece: an epidemiological study of a population in a sunny Mediterranean climate.
Rigopoulos D; Gregoriou S; Katrinaki A; Korfitis C; Larios G; Stamou C; Mourellou O; Petridis A; Rallis E; Sotiriadis D; Katsambas AD; Antoniou C
Eur J Dermatol; 2010; 20(2):189-95. PubMed ID: 20123642
[TBL] [Abstract][Full Text] [Related]
18. Assessment of disease progress in psoriasis.
Marks R; Barton SP; Shuttleworth D; Finlay AY
Arch Dermatol; 1989 Feb; 125(2):235-40. PubMed ID: 2643928
[TBL] [Abstract][Full Text] [Related]
19. Improvement of psoriatic onychodystrophy by a water-soluble nail lacquer.
Cantoresi F; Sorgi P; Arcese A; Bidoli A; Bruni F; Carnevale C; Calvieri S
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):832-4. PubMed ID: 19470045
[TBL] [Abstract][Full Text] [Related]
20. The psoriasis disability index in Chinese patients: contribution of clinical and psychological variables.
Yang Y; Koh D; Khoo L; Nyunt SZ; Ng V; Goh CL
Int J Dermatol; 2005 Nov; 44(11):925-9. PubMed ID: 16336525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
